Cactus Inc
NYSE:WHD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Cactus Inc
Cash Equivalents
Cactus Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cactus Inc
NYSE:WHD
|
Cash Equivalents
$194.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Baker Hughes Co
NYSE:BKR
|
Cash Equivalents
$2.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
9%
|
|
Schlumberger NV
NYSE:SLB
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Halliburton Co
NYSE:HAL
|
Cash Equivalents
$1.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-1%
|
|
W
|
Weatherford International PLC
NASDAQ:WFRD
|
Cash Equivalents
$824m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Cactus Inc's Cash Equivalents?
Cash Equivalents
194.3m
USD
Based on the financial report for Mar 31, 2024, Cactus Inc's Cash Equivalents amounts to 194.3m USD.
What is Cactus Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
17%
Over the last year, the Cash Equivalents growth was 158%. The average annual Cash Equivalents growth rates for Cactus Inc have been -13% over the past three years , 17% over the past five years .